Prior COVID offers less protection vs Omicron; mRNA booster shot efficacy declines within months

Prior COVID offers less protection vs Omicron; mRNA booster shot efficacy declines within months

Published by
Reuters

By Nancy Lapid (Reuters) – The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review. Previous COVID-19 less protective against Omicron variant The immune response to COVID-19 helps protect against reinfection, but that protection is weaker against Omicron than it was against earlier variants of the coronavirus, according to new data. A previous SARS-CoV-2 infection protects against Omicron reinfection only 56% of the time, researchers found in a review of national…

WHO Approves Two New Drugs to Treat COVID-19

The World Health Organization is recommending two new drugs for the treatment of COVID-19, adding to a growing list of therapeutic remedies for the deadly disease.Baricitinib is an oral medication recommended for patients with severe or critical COVID-...

CDC Encourages More Americans to Consider N95 Masks

U.S. health officials on Friday encouraged more Americans to wear the kind of N95 or KN95 masks used by health care workers to slow the spread of the coronavirus.Those kinds of masks are considered better at filtering the air. But they were in short su...

Masks Rules Get Tighter in Europe in winter’s COVID-19 Wave

To mask or not to mask is a question Italy settled early in the COVID-19 outbreak with a vigorous “yes.” Now the onetime epicenter of the pandemic in Europe hopes even stricter mask rules will help it beat the latest infection surge.Other countries are...